Europe Genetic Testing Market By Type (Predictive and Presymptomatic Carrier Testing, Prenatal and Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, and Other Types) By Technology (Cytogenetic Testing, Biochemical Testing and Molecular Testing) By Application (Cancer Diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis and Other Applications)

Analysis of Market Size & Trends

The Europe Genetic Testing Market would witness market growth of 10.8% CAGR during the forecast period (2019-2025).

In the past couple of decades, the market for genetic testing has witnessed rapid development. The growing technological developments have opened up several market expansion possibilities. The rise in chronic disease prevalence and the creation of customized test kits for niche therapeutic fields contribute to the accelerated market growth.

A wide variety of advantages provided by genetic testing, including an understanding of genetic changes in the fetus that may lead to unusual growth and improved knowledge of genetic diseases and disorders, contribute significantly to the growth of the market for genetic testing during the forecast period. Growing understanding of such conditions and disorders has led more individuals to go and test themselves and their family members to gain a stronger awareness of their genetic structure. This has resulted in a growing audience for genetic testing, expanding the markets growth chart to new stages. In addition, changes in food habits, pollution, and exposure to damaging chemicals radiation contribute to rising genetic disease incidence, accelerating the industry exponentially.

Click Here For Free Insights

Based on Type, the market is segmented into Predictive and Presymptomatic Carrier Testing, Prenatal and Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, and Other Types. Based on Technology, the market is segmented into Cytogenetic Testing, Biochemical Testing and Molecular Testing. Based on Application, the market is segmented into Cancer Diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis and Other Applications. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Myriad Genetics, Inc., Empire Genomics LLC, Bio-Rad Laboratories, Inc., Novartis AG, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Danaher Corporation, and Abbott Laboratories (Abbott Laboratories Molecular, Inc.).

Scope of the Genetic Testing Market Analysis

Market Segmentation:

By Type

• Predictive and Presymptomatic Carrier Testing
• Prenatal and Newborn Testing
• Diagnostic Testing
• Pharmacogenomic Testing
• Other Types

By Technology

• Cytogenetic Testing
• Biochemical Testing and
• Molecular Testing

By Application

• Cancer Diagnosis
• Genetic Disease Diagnosis
• Cardiovascular Disease Diagnosis and
• Other Applications

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Companies Profiled

• Myriad Genetics, Inc.
• Empire Genomics LLC
• Bio-Rad Laboratories, Inc.
• Novartis AG
• Agilent Technologies, Inc.
• Thermo Fisher Scientific, Inc.
• Qiagen N.V.
• Illumina, Inc.
• Danaher Corporation
• Abbott Laboratories (Abbott Laboratories Molecular, Inc.)